Pharmacyclics, Inc. (PCYC) Posts Narrower than Expected Q1 Loss of 14c/Share

Pharmacyclics, Inc. (NASDAQ: PCYC) reported Q1 EPS of ($0.14), $0.09 better than the analyst estimate of ($0.23). Revenue for the quarter came in at $1.93 million versus the consensus estimate of $3.14 million.

For earnings history and earnings-related data on Pharmacyclics, Inc. (PCYC) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• zSpace, Inc. (ZSPC) Reports Q2 results